XJPX
3636
Market cap483mUSD
Oct 09, Last price
5,010.00JPY
1D
3.51%
1Q
8.09%
Jan 2017
52.28%
IPO
78.93%
Name
Mitsubishi Research Institute Inc
Chart & performance
P/E
12.36
P/S
0.65
EPS
405.22
Div yield, %
3.41%
Shrs. gr., 5y
-0.63%
Rev. gr., 5y
5.71%
Revenues
121.46b
+5.28%
Net income
6.39b
+27.62%
CFO
6.42b
-52.55%
Dividend
Sep 29, 202685 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Mitsubishi Research Institute, Inc. (MRI) is a Japanese firm that delivers a wide array of strategic advisory, information technology, and research services. It caters to a diverse client base within Japan, encompassing governmental entities, financial organizations, and private corporations. The company's extensive solutions span areas such as management consultation, digital and financial innovation, environmental and energy initiatives, healthcare and wellness, regional development, future infrastructure deployment, scientific and safety research, nuclear safety, and broad economic, social, and R&D initiatives. Furthermore, MRI handles specialized project engagements and public sector procurement. In a key collaboration, it partners with ForePaaS SAS to implement cloud-native data-intensive solutions across Japan. Established in 1970, Mitsubishi Research Institute, Inc. is headquartered in Tokyo.
Key people
Chairman of the Board · since 2021
Seiichiro Akita
Executive Vice President · since 2025
Executive Vice President, Representative Director · since 2025
Jun Nobe
Managing Executive Officer · since 2023
Tetsuya Hanyu
Executive Officer · since 2024
Kazuo Hiyane
Executive Officer, Manager of Generative AI Lab Center · since 2023
Takashi Inoue
Executive Officer · since 2024
Masatsugu Kimoto
Executive Officer, Chairman of Subsidiary · since 2023
Takahisa Maema
Executive Officer · since 2025
Tatsuya Nakabushi
Executive Officer · since 2025
Minoru Sonoyama
Executive Officer · since 2025
Hirofumi Suzuki
Executive Officer, Manager of Public Works · since 2025
Tomoyuki Takahashi
Executive Officer · since 2024
Keitaro Tanaka
Executive Officer, Director of Strategic Planning, Manager of Company-wide Functions · since 2025
Koichiro Uozumi
Executive Officer, Director of Business Planning, Manager of General Affairs Office · since 2025
Executive Officer, Director of Human Resources · since 2023
Yoshihiko Ito
Senior Managing Executive Officer, Director · since 2025
Kenji Yabuta
Executive President, Representative Director · since 2025
Mariko Bando
Independent Director · since 2019
Independent Director · since 2021
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑09 | 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||